SURINDER P DHILLON

Allopathic & Osteopathic Physicians|Internal Medicine FRESNO, CA NPI 1386750487

General Payments — all program years on this page

$5,822.09

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 319
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $319.59 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $319.5916

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,505.20103
2019 $1,073.5856
2020 $1,297.7468
2021 $654.8926
2023 $971.0950
2024 $319.5916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096898683 Novo Nordisk Inc $15.59 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097412947 Novo Nordisk Inc $18.88 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103635984 ABBVIE INC. $32.31 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103635986 ABBVIE INC. $13.20 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104440669 AstraZeneca Pharmaceuticals LP $23.43 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104590180 AstraZeneca Pharmaceuticals LP $20.44 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105503784 AstraZeneca Pharmaceuticals LP $20.99 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117480566 BioCryst US Sales Co., LLC $23.68 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117540966 Amgen Inc. $26.27 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117990350 Boehringer Ingelheim Pharmaceuticals, Inc. $22.11 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130975240 PFIZER INC. $14.42 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131156654 PFIZER INC. $17.44 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135420969 Lilly USA, LLC $16.84 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137530357 Takeda Pharmaceuticals U.S.A., Inc. $13.66 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151055659 Phathom Pharmaceuticals, Inc. $23.74 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153718397 IRONWOOD PHARMACEUTICALS, INC $16.59 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.